Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy
暂无分享,去创建一个
Claes Wahlestedt | Ola Larsson | Carl Johan Sundberg | Jonathan Rachman | C. Wahlestedt | J. Timmons | O. Larsson | T. Gustafsson | C. Sundberg | P. Greenhaff | M. Peyrard-Janvid | James A Timmons | Myriam Peyrard-Janvid | H. Fischer | E. Jansson | Eva Jansson | Helene Fischer | Thomas Gustafsson | Paul L Greenhaff | John Ridden | J. Ridden | J. Rachman
[1] J. Winer,et al. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.
[2] Claes Wahlestedt,et al. Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model , 2004, Cancer Research.
[3] W L Haskell,et al. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. , 1988, The New England journal of medicine.
[4] Eric P Hoffman,et al. Functional characteristics of dystrophic skeletal muscle: insights from animal models. , 2002, Journal of applied physiology.
[5] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[6] F. Andreozzi,et al. PED/PEA‐15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus , 1998, The EMBO journal.
[7] T. Pawson,et al. Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice , 2002, The Journal of experimental medicine.
[8] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] J. Manson,et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.
[10] W. Garvey,et al. Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. , 1998, Diabetes.
[11] G. Condorelli,et al. Protein kinase C (PKC)-alpha activation inhibits PKC-zeta and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. , 2001, Diabetes.
[12] M. Pampusch,et al. Role of insulin‐like growth factor binding protein (IGFBP)‐3 in TGF‐β‐ and GDF‐8 (myostatin)‐induced suppression of proliferation in porcine embryonic myogenic cell cultures , 2003, Journal of cellular physiology.
[13] N. Inestrosa,et al. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation , 2004, Journal of Cell Science.
[14] C. Sylvén,et al. Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure , 2001, European journal of heart failure.
[15] U. Mayer. Integrins: Redundant or Important Players in Skeletal Muscle?* , 2003, The Journal of Biological Chemistry.
[16] M. Rudnicki. Marrow to muscle, fission versus fusion , 2003, Nature Medicine.
[17] P. Carmeliet,et al. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. , 2001, Blood.
[18] A. Geirsson,et al. Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes. , 2003, Biochemical and biophysical research communications.
[19] Mei Han,et al. Gene expression profiling of Duchenne muscular dystrophy skeletal muscle , 2003, Neurogenetics.
[20] A. Butte,et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] T. Suuronen,et al. Type IV collagen and its degradation in paralyzed human muscle: Effect of functional electrical stimulation , 2000, Muscle & nerve.
[22] E. Sage,et al. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF‐dependent signaling , 2003, Journal of cellular biochemistry.
[23] I. Nonaka,et al. Transforming growth factor‐β2 is elevated in skeletal muscle disorders , 1999, Muscle & nerve.
[24] I. Nonaka,et al. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. , 1997, Journal of cell science.
[25] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[26] R S Paffenbarger,et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.
[27] J. Carson,et al. Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. , 2000, Journal of applied physiology.
[28] C. Chung,et al. Involvement of protein phosphatase-1-mediated MARCKS translocation in myogenic differentiation of embryonic muscle cells. , 2002, Journal of cell science.
[29] S. Goldstein,et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.
[30] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Carey,et al. Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. , 2002, Journal of cell science.
[32] Stephen J. Kaufman,et al. Enhanced Expression of the α7β1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice , 2001, The Journal of cell biology.
[33] G. Lynch,et al. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. , 2002, The American journal of pathology.
[34] L. Kunkel,et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Hoeflich,et al. IGF-binding protein-5: flexible player in the IGF system and effector on its own. , 2002, The Journal of endocrinology.
[36] D. Gullberg. Cell biology: The molecules that make muscle , 2003, Nature.
[37] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[38] A. De Luca,et al. Enhanced Dystrophic Progression in mdx Mice by Exercise and Beneficial Effects of Taurine and Insulin-Like Growth Factor-1 , 2003, Journal of Pharmacology and Experimental Therapeutics.
[39] A. Monaco,et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.
[40] S. Bonner-Weir,et al. Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2. , 2000, Endocrinology.
[41] Simon W. Jones,et al. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] B. Haendler,et al. Delineation of the calcineurin‐interacting region of cyclophilin B , 2000, Protein science : a publication of the Protein Society.
[43] E. Olson,et al. Calcineurin Signaling and Muscle Remodeling , 2000, Cell.
[44] F. Booth,et al. Transcriptional profiling identifies extensive downregulation of extracellular matrix gene expression in sarcopenic rat soleus muscle. , 2003, Physiological genomics.
[45] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[46] I. Macdonald,et al. Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise. , 1998, The Journal of clinical investigation.
[47] D. Górecki,et al. Developmental and tissue-specific regulation of mouse dystrophin: The embryonic isoform in muscular dystrophy , 1991, Neuromuscular Disorders.
[48] C. Reggiani,et al. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency , 2003, Nature Genetics.
[49] Eric P. Hoffman,et al. Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .
[50] Eric P Hoffman,et al. A web-accessible complete transcriptome of normal human and DMD muscle , 2002, Neuromuscular Disorders.
[51] Robert A. Harris,et al. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. , 2004, Diabetes.
[52] W. Kraus,et al. PGC-1α mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle , 2004 .
[53] J. Ricort. Insulin-like growth factor binding protein (IGFBP) signalling. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[54] T. Khurana,et al. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions , 2004, Journal of Molecular Medicine.
[55] C. Kahn,et al. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. , 1993, Science.
[56] H. Vestergaard,et al. Insulin resistance and maximal oxygen uptake , 2003, Clinical cardiology.
[57] Andrew P. Weir,et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.